{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:33:20Z","timestamp":1793392400012,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Atopic dermatitis (AD) is one of the most frequent chronic and inflammatory skin condition. AD is characterized by damaged epidermal barrier, xerosis and pruritus of eczematous skin lesions which tend to flare. The duration and frequency of exacerbation of AD symptoms markedly affects the quality of patient life. AD results from the interplay between host genetics, immunity, and environmental factors, however the detailed pathogenesis of this disease is still not entirely cleared. Furthermore, disturbances of the skin microbiota and skin functional impairment predispose to secondary skin infections.\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      colonizes skin and mucous membranes of 20 to 80% of healthy individuals and of 90% of patients with AD in whom this bacterium is accounted as an important AD exacerbating factor. It is also proven, that\n                      <jats:italic>S. aureus<\/jats:italic>\n                      nasal carriage significantly increases the risk for self-transmission and endogenous infection. In the current study the presence of\n                      <jats:italic>S. aureus<\/jats:italic>\n                      either in nasal vestibule and on lesioned skin of 64 patients with AD enrolled in 10-year autovaccination program was determined. The genetic relatedness of 86\u2009\n                      <jats:italic>S. aureus<\/jats:italic>\n                      isolated from patients nose and skin using Pulsed Field Gel Electrophoresis (PFGE) and antimicrobial susceptibility of all strains to methicillin, erythromycin, clindamycin, mupirocin, gentamicin, amikacin, tetracycline, chloramphenicol and cotrimoxazole was also evaluated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total 23 PFGE genotypes and 24 unique patterns were distinguished. 34 patients were\n                      <jats:italic>S. aureus<\/jats:italic>\n                      nasal carriers. Simultaneous presence of\n                      <jats:italic>S. aureus<\/jats:italic>\n                      in nose and on affected skin was found in 16 carriers colonized by indistinguishable or potentially related\n                      <jats:italic>S. aureus<\/jats:italic>\n                      vs 2 carriers colonized with non-related\n                      <jats:italic>S. aureus<\/jats:italic>\n                      in nasal vestibule and on skin.\n                    <\/jats:p>\n                    <jats:p>4 isolates were methicillin resistant (MRSA) among which 3 showed constitutive MLSB resistance phenotype and remaining one was resistant to tetracycline and chloramphenicol.<\/jats:p>\n                    <jats:p>\n                      In 4 isolates inducible MLSB resistance phenotype was found, one of them was additionally resistant to tetracycline. 7\u2009\n                      <jats:italic>S. aureus<\/jats:italic>\n                      were mupirocin resistant among them 3 - isolated from one patient, were resistant simultaneously to tetracyclines and chloramphenicol. 7 strains demonstrated resistance to chloramphenicol and susceptibility to all tested antimicrobial agents. The susceptibility to gentamicin, amikacin and cotrimoxazole among all examined\n                      <jats:italic>S. aureus<\/jats:italic>\n                      was confirmed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The obtained results indicated non-clonal structure of\n                      <jats:italic>S. aureus<\/jats:italic>\n                      circulating in AD patients. PFGE results showed the clonal-structure of vast majority of\n                      <jats:italic>S. aureus<\/jats:italic>\n                      isolated from nose and skin from nasal carriers what may prove the autoinfection in these patients. All examined patients the moderate or strong severity of AD was reported. Susceptibility to most antibiotics among isolated strains was also observed.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-021-06382-3","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T20:02:42Z","timestamp":1626984162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Determination of nasal carriage and skin colonization, antimicrobial susceptibility and genetic relatedness of Staphylococcus aureus isolated from patients with atopic dermatitis in Szczecin, Poland"],"prefix":"10.1186","volume":"21","author":[{"given":"Helena","family":"Masiuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Wcis\u0142ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Jursa-Kulesza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,23]]},"reference":[{"issue":"4","key":"6382_CR1","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3390\/jcm8040444","volume":"8","author":"J Kim","year":"2019","unstructured":"Kim J, Kim H. Microbiome of the skin and gut in atopic dermatitis (AD): understanding the pathophysiology and finding novel management strategies. J Clin Med. 2019;8(4):444. https:\/\/doi.org\/10.3390\/jcm8040444.","journal-title":"J Clin Med"},{"key":"6382_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/354250","volume":"2014","author":"SF Thomsen","year":"2014","unstructured":"Thomsen SF. Atopic dermatitis: natural history, diagnosis, and treatment. ISRN Allergy. 2014;2014:1\u20137. https:\/\/doi.org\/10.1155\/2014\/354250.","journal-title":"ISRN Allergy"},{"issue":"10","key":"6382_CR3","first-page":"16","volume":"6","author":"J Levin","year":"2013","unstructured":"Levin J, Friedlander SF, Del Rosso JQ. Atopic dermatitis and the stratum corneum: part 1: the role of filaggrin in the stratum corneum barrier and atopic skin. J Clin Aesthet Dermatol. 2013;6(10):16\u201322. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24155988. .","journal-title":"J Clin Aesthet Dermatol"},{"issue":"3","key":"6382_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/J.ALIT.2019.02.006","volume":"68","author":"K Iwamoto","year":"2019","unstructured":"Iwamoto K, Moriwaki M, Miyake R, Hide M. Staphylococcus aureus in atopic dermatitis: strain-specific cell wall proteins and skin immunity. Allergol Int. 2019;68(3):309\u201315. https:\/\/doi.org\/10.1016\/J.ALIT.2019.02.006.","journal-title":"Allergol Int"},{"issue":"1","key":"6382_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/1203475415605498","volume":"20","author":"CW Lynde","year":"2016","unstructured":"Lynde CW, Andriessen A, Bertucci V, McCuaig C, Skotnicki S, Weinstein M, et al. The skin microbiome in atopic dermatitis and its relationship to emollients. J Cutaneous Med Surg. 2016;20(1):21\u20138. https:\/\/doi.org\/10.1177\/1203475415605498.","journal-title":"J Cutaneous Med Surg"},{"issue":"1","key":"6382_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1399-3038.2007.00586.x","volume":"19","author":"E Machura","year":"2008","unstructured":"Machura E, Mazur B, Golemiec E, Pindel M, Halkiewicz F. Staphylococcus aureus skin colonization in atopic dermatitis children is associated with decreased IFN-\u03b3 production by peripheral blood CD4 + and CD8+ T cells. Pediatr Allergy Immunol. 2008;19(1):37\u201345. https:\/\/doi.org\/10.1111\/j.1399-3038.2007.00586.x.","journal-title":"Pediatr Allergy Immunol"},{"issue":"3","key":"6382_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1001\/jamadermatol.2017.5440","volume":"154","author":"ML Clausen","year":"2018","unstructured":"Clausen ML, Agner T, Lilje B, Edslev SM, Johannesen TB, Andersen PS. Association of disease severity with skin microbiome and filaggrin gene mutations in adult atopic dermatitis. JAMA Dermatol. 2018;154(3):293\u2013300. https:\/\/doi.org\/10.1001\/jamadermatol.2017.5440.","journal-title":"JAMA Dermatol"},{"issue":"6","key":"6382_CR8","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.tim.2017.11.008","volume":"26","author":"JA Geoghegan","year":"2018","unstructured":"Geoghegan JA, Irvine AD, Foster TJ. Staphylococcus aureus and atopic dermatitis: a complex and evolving relationship. Trends Microbiol. 2018;26(6):484\u201397. https:\/\/doi.org\/10.1016\/j.tim.2017.11.008.","journal-title":"Trends Microbiol"},{"issue":"12","key":"6382_CR9","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S1473-3099(05)70295-4","volume":"5","author":"HFL Wertheim","year":"2005","unstructured":"Wertheim HFL, Melles DC, Vos MC, Van Leeuwen W, Van Belkum A, Verbrugh HA, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005;5(12):751\u201362. https:\/\/doi.org\/10.1016\/S1473-3099(05)70295-4.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"6382_CR10","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1111\/j.1365-2133.2007.08197.x","volume":"157","author":"F Durupt","year":"2007","unstructured":"Durupt F, Mayor L, Bes M, Reverdy M-E, Vandenesch F, Thomas L, et al. Prevalence of Staphylococcus aureus toxins and nasal carriage in furuncles and impetigo. Br J Dermatol. 2007;157(6):1161\u20137. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08197.x.","journal-title":"Br J Dermatol"},{"issue":"3","key":"6382_CR11","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1111\/j.1523-1755.2005.00174.x","volume":"67","author":"JL Nouwen","year":"2005","unstructured":"Nouwen JL, Fieren MWJA, Snijders S, Verbrugh HA, Van Belkum A. Persistent (not intermittent) nasal carriage of Staphylococcus aureus is the determinant of CPD-related infections. Kidney Int. 2005;67(3):1084\u201392. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00174.x.","journal-title":"Kidney Int"},{"key":"6382_CR12","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.3389\/fmicb.2018.02419","volume":"9","author":"A Sakr","year":"2018","unstructured":"Sakr A, Br\u00e9geon F, M\u00e8ge J-L, Rolain J-M, Blin O. Staphylococcus aureus nasal colonization: an update on mechanisms, epidemiology, risk factors, and subsequent infections. Front Microbiol. 2018;9:2419. https:\/\/doi.org\/10.3389\/fmicb.2018.02419.","journal-title":"Front Microbiol"},{"issue":"1","key":"6382_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/1721727X1301100110","volume":"11","author":"A Szkaradkiewicz","year":"2013","unstructured":"Szkaradkiewicz A, Karpi\u0144ski TM, Go\u015bli\u0144ska-Paw\u0141owska O, Szkaradkiewicz AK, Giedrys-Kalemba S. Cytokine response in autovaccine-treated patients with chronic Staphylococcus aureus infections. Eur J Inflamm. 2013;11(1):103\u201310. https:\/\/doi.org\/10.1177\/1721727X1301100110.","journal-title":"Eur J Inflamm"},{"issue":"6","key":"6382_CR14","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s10096-010-1136-3","volume":"30","author":"S Holtfreter","year":"2011","unstructured":"Holtfreter S, Jursa-Kulesza J, Masiuk H, Verkaik NJ, Vogel C, Kolata J, et al. Antibody responses in furunculosis patients vaccinated with autologous formalin-killed Staphylococcus aureus. Eur J Clin Microbiol Infect Dis. 2011;30(6):707\u201317. https:\/\/doi.org\/10.1007\/s10096-010-1136-3.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"6382_CR15","unstructured":"Centers for Disease Control and Prevention (CDC). Unified PulsedField Gel Electrophoresis (PFGE) protocol for gram positive bacteria. Atlanta: Centers for Disease Control and Prevention (CDC); 2012. https:\/\/www.cdc.gov\/hai\/pdfs\/labsettings\/unified_pfge_protocol.pdf."},{"key":"6382_CR16","unstructured":"European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters. 2021. p. 0\u201377.\u00a0 http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_5.0_Breakpoint_Table_01.pdf."},{"issue":"9","key":"6382_CR17","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1128\/jcm.33.9.2233-2239.1995","volume":"33","author":"FC Tenover","year":"1995","unstructured":"Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed- field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33(9):2233\u20139. https:\/\/doi.org\/10.1128\/jcm.33.9.2233-2239.1995.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"6382_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.anai.2018.12.003","volume":"122","author":"T Nakatsuji","year":"2019","unstructured":"Nakatsuji T, Gallo RL. The role of the skin microbiome in atopic dermatitis. Ann Allergy Asthma Immunol. 2019;122(3):263\u20139. https:\/\/doi.org\/10.1016\/j.anai.2018.12.003.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1 I","key":"6382_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0091-6749(99)70536-1","volume":"103","author":"H Williams","year":"1999","unstructured":"Williams H, Robertson C, Stewart A, A\u00eft-Khaled N, Anabwani G, Anderson R, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J Allergy Clin Immunol. 1999;103(1 I):125\u201338. https:\/\/doi.org\/10.1016\/S0091-6749(99)70536-1.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"6382_CR20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.det.2017.02.002","volume":"35","author":"JI Silverberg","year":"2017","unstructured":"Silverberg JI. Public health burden and epidemiology of atopic dermatitis. Dermatol Clin. 2017;35(3):283\u20139. https:\/\/doi.org\/10.1016\/j.det.2017.02.002.","journal-title":"Dermatol Clin"},{"issue":"7689","key":"6382_CR21","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature25177","volume":"553","author":"Y Erin Chen","year":"2018","unstructured":"Erin Chen Y, Fischbach MA, Belkaid Y. Skin microbiota-host interactions. Nature. 2018;553(7689):427\u201336. https:\/\/doi.org\/10.1038\/nature25177.","journal-title":"Nature."},{"issue":"4","key":"6382_CR22","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1128\/IAI.00958-10","volume":"79","author":"M Niebuhr","year":"2011","unstructured":"Niebuhr M, Gathmann M, Scharonow H, Mamerow D, Mommert S, Balaji H, et al. Staphylococcal alpha-toxin is a strong inducer of interleukin-17 in humans. Infect Immun. 2011;79(4):1615\u201322. https:\/\/doi.org\/10.1128\/IAI.00958-10.","journal-title":"Infect Immun"},{"issue":"4","key":"6382_CR23","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1067\/mai.2000.105528","volume":"105","author":"R Bunikowski","year":"2000","unstructured":"Bunikowski R, Mielke MEA, Skarabis H, Worm M, Anagnostopoulos I, Kolde G, et al. Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis. J Allergy Clin Immunol. 2000;105(4):814\u20139. https:\/\/doi.org\/10.1067\/mai.2000.105528.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"6382_CR24","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/j.1365-2133.2006.07410.x","volume":"155","author":"JQ Gong","year":"2006","unstructured":"Gong JQ, Lin L, Lin T, Hao F, Zeng FQ, Bi ZG, et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br J Dermatol. 2006;155(4):680\u20137. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07410.x.","journal-title":"Br J Dermatol"},{"key":"6382_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/1956403","volume":"2018","author":"D Nowicka","year":"2018","unstructured":"Nowicka D, Grywalska E. The role of immune defects and colonization of Staphylococcus aureus in the pathogenesis of atopic dermatitis. Anal Cell Pathol. 2018;2018:1\u20137. https:\/\/doi.org\/10.1155\/2018\/1956403.","journal-title":"Anal Cell Pathol"},{"issue":"1","key":"6382_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.anai.2020.08.002","volume":"126","author":"V Wang","year":"2021","unstructured":"Wang V, Boguniewicz J, Boguniewicz M, Ong PY. The infectious complications of atopic dermatitis. Ann Allergy Asthma Immunol. 2021;126(1):3\u201312. https:\/\/doi.org\/10.1016\/j.anai.2020.08.002.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"6382_CR27","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1080\/09540105.2020.1747406","volume":"31","author":"J \u010celakovsk\u00e1","year":"2020","unstructured":"\u010celakovsk\u00e1 J, Buka\u010d J, Va\u0148kov\u00e1 R, Krcmova I, Krejsek J, Andr\u00fds C. Sensitisation to molecular components in patients with atopic dermatitis, relation to asthma bronchiale and allergic rhinitis. Food Agric Immunol. 2020;31(1):600\u201329. https:\/\/doi.org\/10.1080\/09540105.2020.1747406.","journal-title":"Food Agric Immunol"},{"issue":"1","key":"6382_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/09540105.2016.1228838","volume":"28","author":"J \u010celakovsk\u00e1","year":"2017","unstructured":"\u010celakovsk\u00e1 J, Buka\u010d J. Severity of atopic dermatitis in relation to food and inhalant allergy in adults and adolescents. Food Agric Immunol. 2017;28(1):121\u201333. https:\/\/doi.org\/10.1080\/09540105.2016.1228838.","journal-title":"Food Agric Immunol"},{"issue":"10","key":"6382_CR29","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/j.jid.2018.03.1517","volume":"138","author":"EL Simpson","year":"2018","unstructured":"Simpson EL, Villarreal M, Jepson B, Rafaels N, David G, Hanifin J, et al. Patients with atopic dermatitis colonized with Staphylococcus aureus have a distinct phenotype and Endotype. J Invest Dermatol. 2018;138(10):2224\u201333. https:\/\/doi.org\/10.1016\/j.jid.2018.03.1517.","journal-title":"J Invest Dermatol"},{"issue":"7","key":"6382_CR30","doi-asserted-by":"publisher","first-page":"802","DOI":"10.2340\/00015555-2667","volume":"97","author":"M Alsterholm","year":"2017","unstructured":"Alsterholm M, Str\u00f6mbeck L, Ljung A, Karami N, Widjestam J, Gillstedt M, et al. Variation in Staphylococcus aureus colonization in relation to disease severity in adults with atopic dermatitis during a fivemonth follow-up. Acta Derm Venereol. 2017;97(7):802\u20137. https:\/\/doi.org\/10.2340\/00015555-2667.","journal-title":"Acta Derm Venereol"},{"key":"6382_CR31","doi-asserted-by":"publisher","unstructured":"Ogonowska P, Gilaberte Y, Bara\u0144ska-Rybak W, Nakonieczna J. Colonization with Staphylococcus aureus in atopic dermatitis patients: attempts to reveal the unknown. Front Microbiol. 2021. p. 11. https:\/\/doi.org\/10.3389\/fmicb.2020.567090.","DOI":"10.3389\/fmicb.2020.567090"},{"issue":"1","key":"6382_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/jac\/dkp159","volume":"64","author":"T Coates","year":"2009","unstructured":"Coates T, Bax R, Coates A. Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects. J Antimicrob Chemother. 2009;64(1):9\u201315. https:\/\/doi.org\/10.1093\/jac\/dkp159.","journal-title":"J Antimicrob Chemother"},{"key":"6382_CR33","doi-asserted-by":"publisher","first-page":"0104","DOI":"10.1371\/journal.pmed.0050017","volume":"5","author":"HFL Wertheim","year":"2008","unstructured":"Wertheim HFL, Walsh E, Choudhurry R, Melles DC, Boelens HAM, Miajlovic H, et al. Key role for clumping factor B in Staphylococcus aureus nasal colonization of humans. PLoS Med. 2008;5:0104\u201312.","journal-title":"PLoS Med"},{"issue":"12","key":"6382_CR34","first-page":"1350","volume":"58","author":"CH Smith","year":"2012","unstructured":"Smith CH, Goldman RD. Staphylococcus aureus decolonization for recurrent skin and soft tissue infections in children. Can Fam Physician. 2012;58(12):1350\u20132.","journal-title":"Can Fam Physician"},{"issue":"1","key":"6382_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1046\/j.1365-2133.2002.04872.x","volume":"147","author":"K Breuer","year":"2002","unstructured":"Breuer K, H\u00e4ussler S, Kapp A, Werfel T. Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol. 2002;147(1):55\u201361. https:\/\/doi.org\/10.1046\/j.1365-2133.2002.04872.x.","journal-title":"Br J Dermatol"},{"issue":"3","key":"6382_CR36","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1346-8138.1995.tb03366.x","volume":"22","author":"S Namura","year":"1995","unstructured":"Namura S, Nishijima S, Higashida T, Asada Y. Staphylococcus aureus isolated from nostril anteriors and subungual spaces of the hand: comparative study of medical staff, patients, and normal controls. J Dermatol. 1995;22(3):175\u201380. https:\/\/doi.org\/10.1111\/j.1346-8138.1995.tb03366.x.","journal-title":"J Dermatol"},{"issue":"5","key":"6382_CR37","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1399-3038.2004.00182.x","volume":"15","author":"PH Hoeger","year":"2004","unstructured":"Hoeger PH. Antimicrobial susceptibility of skin-colonizing S. aureus strains in children with atopic dermatitis. Pediatr Allergy Immunol. 2004;15(5):474\u20137. https:\/\/doi.org\/10.1111\/j.1399-3038.2004.00182.x.","journal-title":"Pediatr Allergy Immunol"},{"key":"6382_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/718708","volume":"2011","author":"C Pascolini","year":"2011","unstructured":"Pascolini C, Sinagra J, Pecetta S, Bordignon V, De Santis A, Cilli L, et al. Molecular and immunological characterization of Staphylococcus aureus in pediatric atopic dermatitis: implications for prophylaxis and clinical management. Clin Dev Immunol. 2011;2011:1\u20137. https:\/\/doi.org\/10.1155\/2011\/718708.","journal-title":"Clin Dev Immunol"},{"issue":"1","key":"6382_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0195-6701(95)90079-9","volume":"31","author":"RP Wenzel","year":"1995","unstructured":"Wenzel RP, Perl TM. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J Hosp Infect. 1995;31(1):13\u201324. https:\/\/doi.org\/10.1016\/0195-6701(95)90079-9.","journal-title":"J Hosp Infect"},{"issue":"4893","key":"6382_CR40","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1136\/bmj.2.4893.912","volume":"2","author":"LG Tulloch","year":"1954","unstructured":"Tulloch LG. Nasal carriage in staphylococcal skin infections. Br Med J. 1954;2(4893):912\u20133. https:\/\/doi.org\/10.1136\/bmj.2.4893.912.","journal-title":"Br Med J"},{"issue":"2","key":"6382_CR41","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1128\/JCM.01734-07","volume":"46","author":"S Bonness","year":"2008","unstructured":"Bonness S, Szekat C, Novak N, Bierbaum G. Pulsed-field gel electrophoresis of Staphylococcus aureus isolates from atopic patients revealing presence of similar strains in isolates from children and their parents. J Clin Microbiol. 2008;46(2):456\u201361. https:\/\/doi.org\/10.1128\/JCM.01734-07.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"6382_CR42","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3947\/ic.2017.49.2.158","volume":"49","author":"EJ Choo","year":"2017","unstructured":"Choo EJ. Community-associated methicillin-resistant Staphylococcus aureus in nosocomial infections. Infect Chemother. 2017;49(2):158\u20139. https:\/\/doi.org\/10.3947\/ic.2017.49.2.158.","journal-title":"Infect Chemother"},{"issue":"3","key":"6382_CR43","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4103\/1319-1683.74320","volume":"17","author":"H Bukharie","year":"2010","unstructured":"Bukharie H. A review of community-acquired methicillin-resistant Staphylococcus aureus for primary care physicians. J Fam Community Med. 2010;17(3):117\u201320. https:\/\/doi.org\/10.4103\/1319-1683.74320.","journal-title":"J Fam Community Med"},{"issue":"6","key":"6382_CR44","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/j.1365-2133.2008.08817.x","volume":"159","author":"A K\u0229dzierska","year":"2008","unstructured":"K\u0229dzierska A, Kapi\u0144ska-Mrowiecka M, Czubak-Macugowska M, W\u00f3jcik K, K\u0229dzierska J. Susceptibility testing and resistance phenotype detection in Staphylococcus aureus strains isolated from patients with atopic dermatitis, with apparent and recurrent skin colonization. Br J Dermatol. 2008;159(6):1290\u20139. https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08817.x.","journal-title":"Br J Dermatol"},{"issue":"11","key":"6382_CR45","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/j.1600-0625.2008.00734.x","volume":"17","author":"M Niebuhr","year":"2008","unstructured":"Niebuhr M, Mai U, Kapp A, Werfel T. Antibiotic treatment of cutaneous infections with Staphylococcus aureus in patients with atopic dermatitis: current antimicrobial resistances and susceptibilities. Exp Dermatol. 2008;17(11):953\u20137. https:\/\/doi.org\/10.1111\/j.1600-0625.2008.00734.x.","journal-title":"Exp Dermatol"},{"issue":"5","key":"6382_CR46","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/j.1365-2133.2009.09038.x","volume":"160","author":"LS Chiu","year":"2009","unstructured":"Chiu LS, Ho MSL, Hsu LY, Tang MBY. Prevalence and molecular characteristics of Staphylococcus aureus isolates colonizing patients with atopic dermatitis and their close contacts in Singapore. Br J Dermatol. 2009;160(5):965\u201371. https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09038.x.","journal-title":"Br J Dermatol"},{"issue":"3","key":"6382_CR47","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1442-200X.2010.03227.x","volume":"53","author":"CS Tang","year":"2011","unstructured":"Tang CS, Wang CC, Huang CF, Chen SJ, Tseng MH, Lo WT. Antimicrobial susceptibility of Staphylococcus aureus in children with atopic dermatitis. Pediatr Int. 2011;53(3):363\u20137. https:\/\/doi.org\/10.1111\/j.1442-200X.2010.03227.x.","journal-title":"Pediatr Int"},{"issue":"4","key":"6382_CR48","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jaip.2014.04.007","volume":"2","author":"PY Ong","year":"2014","unstructured":"Ong PY. Recurrent MRSA skin infections in atopic dermatitis. J Allergy Clin Immunol Pract. 2014;2(4):396\u20139. https:\/\/doi.org\/10.1016\/j.jaip.2014.04.007.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"6382_CR49","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s12088-012-0296-5","volume":"52","author":"SCR Thumu","year":"2012","unstructured":"Thumu SCR, Halami PM. Acquired resistance to macrolide-Lincosamide-Streptogramin antibiotics in lactic acid Bacteria of food origin. Indian J Microbiol. 2012;52(4):530\u20137. https:\/\/doi.org\/10.1007\/s12088-012-0296-5.","journal-title":"Indian J Microbiol"},{"issue":"4","key":"6382_CR50","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1086\/324626","volume":"34","author":"R Leclercq","year":"2002","unstructured":"Leclercq R. Mechanisms of resistance to macrolides and Lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis. 2002;34(4):482\u201392. https:\/\/doi.org\/10.1086\/324626.","journal-title":"Clin Infect Dis"},{"key":"6382_CR51","doi-asserted-by":"publisher","first-page":"BR48","DOI":"10.12659\/msm.881386","volume":"17","author":"H Saderi","year":"2011","unstructured":"Saderi H, Emadi B, Owlia P. Phenotypic and genotypic study of macrolide, lincosamide and streptogramin B (MLSB) resistance in clinical isolates of Staphylococcus aureus in Tehran, Iran. Med Sci Monit. 2011;17:BR48\u201353. https:\/\/doi.org\/10.12659\/msm.881386.","journal-title":"Med Sci Monit"},{"issue":"1","key":"6382_CR52","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1155\/1998\/538090","volume":"9","author":"M Smieja","year":"1998","unstructured":"Smieja M. Current indications for the use of clindamycin: a critical review. Can J Infect Dis. 1998;9(1):22\u20138. https:\/\/doi.org\/10.1155\/1998\/538090.","journal-title":"Can J Infect Dis"},{"key":"6382_CR53","volume-title":"Methicillin resistant Staphylococcus aureus (MRSA)","author":"AH Siddiqui","year":"2020","unstructured":"Siddiqui AH, Koirala J. Methicillin resistant Staphylococcus aureus (MRSA). 2020. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29489200. Accessed 14 Sep 2020."},{"issue":"6","key":"6382_CR54","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/bjd.18643","volume":"182","author":"H Alexander","year":"2020","unstructured":"Alexander H, Paller AS, Traidl-Hoffmann C, Beck LA, De Benedetto A, Dhar S, et al. The role of bacterial skin infections in atopic dermatitis: expert statement and review from the international eczema council skin infection group. Br J Dermatol. 2020;182(6):1331\u201342. https:\/\/doi.org\/10.1111\/bjd.18643.","journal-title":"Br J Dermatol"},{"issue":"6","key":"6382_CR55","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1177\/030006059101900602","volume":"19","author":"R Daniel","year":"1991","unstructured":"Daniel R. Azithromycin, erythromycin and Cloxacillin in the treatment of infections of skin and associated soft tissues. J Int Med Res. 1991;19(6):433\u201345. https:\/\/doi.org\/10.1177\/030006059101900602.","journal-title":"J Int Med Res"},{"issue":"1","key":"6382_CR56","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1600-065X.2011.01027.x","volume":"242","author":"M Boguniewicz","year":"2011","unstructured":"Boguniewicz M, Leung DYM. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev. 2011;242(1):233\u201346. https:\/\/doi.org\/10.1111\/j.1600-065X.2011.01027.x.","journal-title":"Immunol Rev"},{"issue":"5","key":"6382_CR57","doi-asserted-by":"publisher","first-page":"e808","DOI":"10.1542\/peds.2008-2217","volume":"123","author":"JT Huang","year":"2009","unstructured":"Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics. 2009;123(5):e808\u201314. https:\/\/doi.org\/10.1542\/peds.2008-2217.","journal-title":"Pediatrics."},{"key":"6382_CR58","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jgar.2019.07.032","volume":"20","author":"M Dadashi","year":"2020","unstructured":"Dadashi M, Hajikhani B, Darban-Sarokhalil D, van Belkum A, Goudarzi M. Mupirocin resistance in Staphylococcus aureus: a systematic review and meta-analysis. J Glob Antimicrob Resist. 2020;20:238\u201347. https:\/\/doi.org\/10.1016\/j.jgar.2019.07.032.","journal-title":"J Glob Antimicrob Resist"},{"key":"6382_CR59","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000331910","volume":"96","author":"M Boguniewicz","year":"2012","unstructured":"Boguniewicz M. New strategies for dealing with staphylococcus aureus colonization and the emerging methicillin-resistant staphylococcus aureus epidemic in atopic dermatitis. Chem Immunol Allergy. 2012;96:113\u20139. https:\/\/doi.org\/10.1159\/000331910.","journal-title":"Chem Immunol Allergy"},{"issue":"8","key":"6382_CR60","doi-asserted-by":"publisher","first-page":"e1008733","DOI":"10.1371\/journal.ppat.1008733","volume":"16","author":"MJ Paterson","year":"2020","unstructured":"Paterson MJ, Caldera J, Nguyen C, Sharma P, Castro AM, Kolar SL, et al. Harnessing antifungal immunity in pursuit of a Staphylococcus aureus vaccine strategy. PLoS Pathog. 2020;16(8):e1008733. https:\/\/doi.org\/10.1371\/journal.ppat.1008733.","journal-title":"PLoS Pathog"},{"key":"6382_CR61","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/82_2016_32","volume-title":"Staphylococcus aureus-associated skin and soft tissue infections: anatomical localization, epidemiology, therapy and potential prophylaxis","author":"R Olaniyi","year":"2017","unstructured":"Olaniyi R, Pozzi C, Grimaldi L, Bagnoli F. Staphylococcus aureus-associated skin and soft tissue infections: anatomical localization, epidemiology, therapy and potential prophylaxis: Current Topics in Microbiology and Immunology. Springer Verlag; 2017. p. 199\u2013227. https:\/\/doi.org\/10.1007\/82_2016_32."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06382-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06382-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06382-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T20:02:51Z","timestamp":1626984171000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06382-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,23]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6382"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06382-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,23]]},"assertion":[{"value":"12 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patient data have been collected as the part of the project after obtaining permission (KB-0012\/112\/17) from the Bioethics Comitee of Pomeranian Medical University in Szczecin, Poland. Patient identity remained confidential.In this study informed consent for swab and strains collection was not required as the isolates examined in the current study were collected during the routine microbiological diagnostic in order to prepare the autovaccine.The raw data and samples mentioned in the methods are the property of the Independent Laboratory of Medical Microbiology, Pomeranian Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"701"}}